<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Genmab - Darzalex - Kommentar fra Sydbank.]]></title><description><![CDATA[<p dir="auto">Darzalex - højdepunkter fra Johnson &amp; Johnsons 3. kvartalsregnskab 2020 :</p>
<p dir="auto"><a href="https://data.sydbank.dk/api/investment/sydbank/publications/file/131353" rel="nofollow ugc">https://data.sydbank.dk/api/investment/sydbank/publications/file/131353</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/441978/genmab-darzalex-kommentar-fra-sydbank</link><generator>RSS for Node</generator><lastBuildDate>Thu, 09 Jul 2026 00:15:09 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/441978.rss" rel="self" type="application/rss+xml"/><pubDate>Fri, 16 Oct 2020 06:21:35 GMT</pubDate><ttl>60</ttl></channel></rss>